Esperion raises $70 million in IPO

Esperion Therapeutics Inc. (NASDAQ:ESPR) raised $70 million through the sale of a bumped-up number of shares within its proposed price range. Esperion sold 5 million shares at $14, which values the company at $204.1 million. Earlier this month, Esperion said it planned to sell 4.5 million shares at $13-$15. The company filed to raise up to $70 million in the offering in May. Credit Suisse; Citigroup; JMP Securities; and Stifel Nicolaus Weisel are underwriters. Esperion was up $0.50 to $14.50 in its first day of trading on Wednesday. ...